Hospital Gowns Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Hospital Gowns Market Trends and Insights

Infection Control Mandates And HAI Prevention

Healthcare associated infections continue to create a firm demand floor for the hospital gowns market because prevention protocols require regular gown use in acute care, long term care, and other patient contact settings. WHO reported that healthcare associated infections add 25 million extra hospital days each year in Europe and impose EUR 13-24 billion (USD 15.1 to 27.9 billion) in annual costs, which keeps infection prevention spending difficult to defer. OECD also found that infection prevention and control measures, including appropriate gown use, can reduce infections by up to 70% and return USD 24.6 for every USD 1 invested across OECD and EU and EEA countries^{[1]Organisation for Economic Co-operation and Development, “Health at a Glance, Europe 2024,” OECD, oecd.org}. The burden is even higher in lower income settings, where WHO noted much greater infection incidence, and that pushes large public systems to formalize procurement of protective apparel rather than treat it as a variable line item. In the United States, CDC guidance on Enhanced Barrier Precautions is extending routine gown use into nursing home activities that involve close contact, which broadens the addressable base for the hospital gowns market beyond hospitals alone.

Surgical Volume Growth And Procedural Throughput Requirements

Procedure growth continues to support the hospital gowns market because surgical case recovery has moved beyond backlog clearing and into a broader expansion of outpatient and minimally invasive care pathways. The Lancet projected global surgical volumes at no less than 160 million operations annually, which implies durable consumption of surgical gowns across hospital and ambulatory settings. CMS added 289 procedures to the ASC Covered Procedures List for 2026, which keeps moving more cases into ambulatory settings where throughput matters and disposable configurations remain common. That site of care shift matters because high acuity procedures done in ASCs often use tightly standardized packs and lean room turnover protocols, which increases the operational value of dependable gown supply. As a result, procedure growth is not only lifting unit demand in the hospital gowns market, it is also changing the mix toward products that can support faster turnover, predictable compliance, and easier inventory control.

Rising Preference For Disposable Gowns In High-Turnover Care Settings

Disposable gowns continue to hold a large position in the hospital gowns market because emergency departments, ASCs, and procedural suites value products that remove the need for collection, washing, validation, and redistribution. The preference is strongest where room turnover is fast and where staff want each case to begin with a fresh item that is already qualified for its barrier level. The migration of orthopaedic, cardiovascular, and spine procedures into ambulatory settings strengthens this pattern because those centers often prioritize standardization and speed over textile reprocessing logistics. Regulatory structure also supports this segment because the FDA requires 510(k) clearance for medical gowns that make moderate or high fluid barrier claims, including AAMI Level 4, which raises the value of compliant disposable product lines. This leaves the hospital gowns market in a position where disposables remain the practical choice in high velocity settings, even while reusables gain traction in selected operating room programs.

Sustainability-Led Reusable Gown Procurement In Mature Health Systems

Sustainability goals are creating a second major demand path in the hospital gowns market, especially in mature health systems that now link procurement decisions to waste reduction and emissions targets. Health Innovation North West Coast reported that reusable gown systems can reduce solid waste by up to 93% and greenhouse gas emissions by 66% compared with single use alternatives, which has made the environmental case much easier for procurement teams to defend. In February 2025, Barts Health NHS Trust awarded a 3 year contract covering reusable theatre gowns across 6 sites, with expected annual volume of 400,000 gowns and a projected reduction of 90 tonnes of clinical waste^{[2]Government Commercial Authority, “Greener Gowns for Barts Health NHS Trust Surgical Staff,” Government Commercial Authority, gca.gov.uk}. Policy support is also becoming more visible, with Italy prioritizing reusable operating room textiles and other European systems evaluating how to move from simple product purchasing to service based textile models. This means the hospital gowns market is no longer shaped only by infection control rules, because environmental performance now influences contract design, vendor selection, and long term replacement cycles.

Premium Product Cost Pressure In Budget-Constrained Facilities

Cost pressure remains a real brake on the hospital gowns market because higher barrier garments raise procurement costs for facilities that already face tight operating budgets. The 2025 international study covering 5,230 perioperative professionals across 134 countries found that financial constraints were the most frequently cited barrier to improving gown quality, identified by 19.9% of respondents. The same study showed that infrastructure limits and cost pressures often appear together, which means facilities do not move through adoption stages in a simple sequence. Smaller ASCs, long term care centers, and public hospitals also lack the purchasing leverage available to large integrated networks, so per unit costs can stay structurally higher for them. This keeps part of the hospital gowns market anchored to basic product tiers, even where clinical teams would prefer better comfort, breathability, or barrier performance.

Regulatory And Barrier-Performance Compliance Complexity

Compliance complexity slows parts of the hospital gowns market because suppliers often need to manage overlapping requirements across AAMI, European, and evolving international standards. The FDA framework adds further burden because gowns with moderate or high fluid barrier claims require premarket review, and even a product line change can trigger added testing and submission work. The PMC study on disposable isolation gowns also showed that claimed classifications do not always match real performance, which increases pressure on regulators and hospitals to verify data more closely. The Kimberly-Clark case raised the stakes by showing how compliance failures can become legal action when barrier claims are not backed by consistent testing controls. Larger incumbents can usually absorb these burdens more effectively than newer entrants, so the hospital gowns market still carries a meaningful scale advantage for established suppliers.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Usability: Disposable Volume Persists as Reusable Models Scale

Disposable Gowns held 56.31% of the hospital gowns market share in 2025, which reflected their deep use in acute care hospitals, ASCs, and emergency settings where single patient use remains central to workflow discipline. Their position in the hospital gowns market is supported by fast turnover, simple logistics, and a lower need for internal textile management. Facilities that face unpredictable caseloads or limited reprocessing infrastructure still rely on disposables because they remove the risk of laundry bottlenecks and reduce coordination across departments. This makes disposable volume resilient even as the broader hospital gowns market shifts toward more selective product and service combinations.

Reusable Gowns are forecast to grow at a 10.38% CAGR during 2026-2031, making them the faster moving usability segment as sustainability goals and life cycle cost reviews gain more weight in procurement. The 2025 global perioperative study found that sterilization related limits remain a core barrier, so reusable adoption depends less on clinical acceptance and more on service readiness. In practice, the hospital gowns industry is moving toward coexistence rather than replacement, with reusable programs strongest in planned surgical environments and disposable demand staying firm in emergency, trauma, and outpatient channels. Hybrid procurement models fit this reality well because they let systems use reusable textiles for scheduled operating room volume and keep disposable stock for surge periods and high turnover care. Suppliers that can serve both models should be better placed in the hospital gowns market because buyers increasingly want flexibility instead of a single format commitment.

By Type: Surgical Gowns Lead as Patient Gowns Gain from Ambulatory Expansion

Surgical Gowns accounted for 45.24% share of the hospital gowns market size in 2025, which reflected their mandatory role in operative care and their higher average value under stricter barrier requirements. Their lead in the hospital gowns market is tied to every procedure that demands controlled sterile conditions, including cardiothoracic, orthopedic, laparoscopic, and other fluid exposure settings. Non surgical gowns remain an important institutional category because they support isolation, contact precautions, chemotherapy handling, and other procedural needs shaped by infection control guidance. This keeps type level demand broad based, with surgical, non surgical, and patient use categories responding to different care pathways rather than one common demand pattern.

Patient Gowns are projected to grow at a 10.52% CAGR during 2026-2031, which is a faster pace than the overall hospital gowns market because outpatient care and home based services are expanding. More ambulatory centers and independent clinics are now buying directly instead of drawing from hospital led channels, which is widening the purchasing base for this category. Design upgrades are also giving patient gowns more strategic value, especially where comfort, dignity, and better handling support patient experience goals. In procedural settings, some patient facing garments are also moving closer to standardized fluid protection expectations when exposure risk is present. The result is that patient gowns no longer sit only at the low end of the hospital gowns market, because service model changes are making them a more active source of recurring volume.

By Risk Type: High-Risk Segment Anchors Revenue as Minimal-Risk Category Grows

High Risk Gowns represented 44.52% of hospital gowns market size in 2025, and that value lead came from mandatory use in surgical settings where strong fluid and pathogen resistance are essential. Their pricing power in the hospital gowns market is reinforced by the FDA requirement that products making AAMI Level 4 claims go through 510(k) review, which narrows the pool of credible suppliers. Moderate Risk Gowns remain widely used in general surgery, infusion therapy, and high exposure diagnostics, while Low Risk Gowns continue to serve routine blood draw, IV, and minor procedure environments. This creates a wide demand ladder in the hospital gowns market, where revenue concentration sits higher in the risk spectrum even when unit volumes are spread across several levels.

Minimal Risk Gowns are forecast to grow at an 11.25% CAGR during 2026-2031, making them the fastest growing risk segment as long term care, home health, and ambulatory settings formalize apparel purchasing. CDC guidance on Enhanced Barrier Precautions is directly expanding gown use in nursing homes during high contact resident care activities, which increases demand in settings that often lacked formal gown budgets in the past. ANSI and AAMI PB70:2022 continues to provide the recognized performance framework across all 4 levels, which helps hospital systems align claims, purchasing specifications, and audit requirements. As lower acuity channels become more structured, the hospital gowns market is expanding from the bottom of the risk ladder as well as from the premium surgical tier. That broadens the supplier opportunity set, but it also makes clear product positioning and compliance language more important across the full portfolio.

By End User: Hospital Dominance Persists as ASCs Capture Share

Hospitals and Clinics generated 56.24% of revenue in 2025, which kept them as the core demand center of the hospital gowns market because they concentrate high acuity surgery, isolation demand, and broad procedural activity. Their buying patterns shape product mix across the hospital gowns market because they purchase across all risk levels and both disposable and reusable formats. Long term care facilities are becoming a more formal end user group as infection prevention protocols extend gown use beyond acute care and into resident contact workflows. Home healthcare remains a smaller channel, but it is beginning to generate more structured demand as skilled nursing, wound care, and therapy related visits expand outside hospital walls.

Ambulatory Surgical Centers are forecast to grow at a 9.52% CAGR during 2026-2031, making them the fastest expanding end user group in the hospital gowns market. CMS support for more ASC eligible procedures is a major reason, because it keeps directing cardiovascular, spine, vascular, and orthopedic cases into outpatient surgical settings. This channel leans heavily toward disposables because the care model values quick room turnover, standardized packs, and simpler inventory control over internal laundry operations. As a result, ASC growth does more than add volume, it also influences the future mix of the hospital gowns market toward products that fit speed, compliance, and workflow simplicity. Hospitals will still remain the anchor buyer group, but ASCs are taking a larger role in how suppliers think about design, packaging, and distribution strategy.

Geography Analysis

North America accounted for 38.52% of the hospital gowns market share in 2025, which made it the largest regional contributor on the back of a dense accredited provider base, clear AAMI alignment, and strong purchasing scale. The United States remains the central revenue engine in the hospital gowns market because its hospitals, ASCs, and group purchasing organizations favor suppliers with dependable logistics and strong compliance records. Canada adds a different layer, with centralized procurement and growing interest in reusable gown programs that fit broader health system sustainability goals. Mexico continues to develop as a growth market as public and private providers expand structured procurement for surgical and infection prevention products. Regulatory scrutiny also intensified after the August 2025 DOJ settlement involving adulterated MicroCool surgical gowns, which raised the importance of testing credibility and supplier documentation across North American sourcing decisions.

Europe remains a strategically distinct region in the hospital gowns market because sustainability targets are changing how buyers compare single use and reusable options. Western European systems are moving faster on reusable operating room textiles, and Barts Health NHS Trust provided a visible example in 2025 with a large reusable gown contract tied to waste reduction goals. The regional backdrop is still shaped by a high infection burden, with OECD reporting around 4.3 million healthcare associated infection episodes each year in EU acute care hospitals, which sustains the baseline need for gowns across member states. This leaves Europe with a dual demand structure in the hospital gowns market, where infection control keeps volumes steady while sustainability policy changes the preferred textile model.

Asia-Pacific is forecast to expand at a 9.55% CAGR during 2026-2031, making it the fastest growing regional block in the hospital gowns market. China held the largest regional share in 2025 as hospital expansion, procurement rationalization, and export capability strengthened the role of validated gown categories. India is also adding scale through government backed hospital expansion and a growing private system that demands higher performance products. The Middle East and Africa shows a split pattern, with GCC systems moving toward international standards and local production initiatives such as Mölnlycke's Saudi joint venture, while much of sub Saharan Africa remains limited by budget and infrastructure constraints^{[3]Mölnlycke Health Care, “Tamer Mölnlycke Care Celebrates a New Chapter in Healthcare in the Kingdom of Saudi Arabia,” Mölnlycke, molnlycke.com}. South America is being supported by structured public and private procurement in Brazil and a gradual normalization of institutional purchasing in Argentina.